首页 > 最新文献

Case Reports in Nephrology最新文献

英文 中文
From the Old, the Best: Parathyroidectomy in the Management of Soft-Tissue and Vascular Calcification in Patients with Chronic Renal Disease. 从老到好:甲状旁腺切除术治疗慢性肾病患者软组织和血管钙化。
Pub Date : 2021-11-09 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9985308
P Mariel Hernandez, B Daniel Enos, T Gonzalo Labarca, A Guillermo Vanderstelt

Introduction. Bone mineral disease in patients with chronic kidney disease (CKD-MBD) is a clinical syndrome involving bone, biochemical changes, and extraosseous calcification. These complications increase morbidity and mortality. Prevalence reports are rare. Case Report. This case shows a young woman on peritoneal dialysis (PD) for 10 years with severe secondary hyperparathyroidism and soft-tissue calcifications in the hands, pelvis, and right knee, as well as severe vascular calcification, managed with calcimimetics without success. We decided to perform subtotal parathyroidectomy (STPTX). Three months after surgery, she had satisfactory evolution, despite notable hungry bone disease, without bone pain or functional limitation and almost no calcifications. Discussion. The benefit of hemodialysis has been shown with better volume management and improvement of calcium/phosphate products. STPTX allowed biochemical control and calcification improvement, with an evident better quality of life for our patient. Therapeutic alternatives need to be tailored to the patient's characteristics in the calcimimetics era.

介绍。慢性肾病患者的骨矿物质病(CKD-MBD)是一种涉及骨骼、生化变化和骨外钙化的临床综合征。这些并发症增加了发病率和死亡率。患病率报告很少。病例报告。该病例显示一名接受腹膜透析(PD) 10年的年轻女性,患有严重的继发性甲状旁腺功能亢进,手部、骨盆和右膝软组织钙化,以及严重的血管钙化,使用钙化剂治疗均未成功。我们决定行甲状旁腺次全切除术(STPTX)。手术后3个月,患者进展满意,尽管有明显的饥饿骨病,没有骨痛或功能限制,几乎没有钙化。讨论。血液透析的好处已经显示出更好的容量管理和改善钙/磷酸盐产品。STPTX使生化控制和钙化改善,明显改善了患者的生活质量。治疗方案需要量身定制的病人的特点,在石灰化时代。
{"title":"From the Old, the Best: Parathyroidectomy in the Management of Soft-Tissue and Vascular Calcification in Patients with Chronic Renal Disease.","authors":"P Mariel Hernandez,&nbsp;B Daniel Enos,&nbsp;T Gonzalo Labarca,&nbsp;A Guillermo Vanderstelt","doi":"10.1155/2021/9985308","DOIUrl":"https://doi.org/10.1155/2021/9985308","url":null,"abstract":"<p><p><i>Introduction</i>. Bone mineral disease in patients with chronic kidney disease (CKD-MBD) is a clinical syndrome involving bone, biochemical changes, and extraosseous calcification. These complications increase morbidity and mortality. Prevalence reports are rare. <i>Case Report</i>. This case shows a young woman on peritoneal dialysis (PD) for 10 years with severe secondary hyperparathyroidism and soft-tissue calcifications in the hands, pelvis, and right knee, as well as severe vascular calcification, managed with calcimimetics without success. We decided to perform subtotal parathyroidectomy (STPTX). Three months after surgery, she had satisfactory evolution, despite notable hungry bone disease, without bone pain or functional limitation and almost no calcifications. <i>Discussion</i>. The benefit of hemodialysis has been shown with better volume management and improvement of calcium/phosphate products. STPTX allowed biochemical control and calcification improvement, with an evident better quality of life for our patient. Therapeutic alternatives need to be tailored to the patient's characteristics in the calcimimetics era.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39638210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Roseomonas mucosa-Induced Peritonitis in a Patient Undergoing Continuous Cycler Peritoneal Dialysis: Case Report and Literature Analysis. 连续循环腹膜透析患者的黏膜玫瑰单胞菌性腹膜炎:病例报告和文献分析。
Pub Date : 2021-11-01 eCollection Date: 2021-01-01 DOI: 10.1155/2021/1979332
Sasmit Roy, Sumit Patel, Hardhik Kummamuru, Amarinder Singh Garcha, Rohan Gupta, Sreedhar Adapa

Roseomonas species, a rare Gram-negative microorganism, has seldom been reported to cause peritonitis in end-stage renal disease patients on peritoneal dialysis. Only seven cases of peritonitis by this rare microorganism have been reported worldwide. Treatment options can be challenging if not detected early and can lead to significant morbidity and mortality along with the switching of the dialysis modality to hemodialysis which is highly undesirable. Our patient is a 65-year-old Caucasian female who needed to be changed to emergency hemodialysis due to inability to perform peritoneal dialysis from suspected peritonitis and was subsequently discovered to have peritonitis from Roseomonas mucosa. She recovered with a prolonged antibiotics course and returned to peritoneal dialysis in 3 months following her treatment completion. Prompt diagnosis and prolonged antibiotics are a cornerstone in the management of this rare microorganism to prevent mortality and morbidity from peritonitis.

玫瑰单胞菌是一种罕见的革兰氏阴性微生物,很少被报道在腹膜透析的终末期肾病患者中引起腹膜炎。这种罕见微生物引起的腹膜炎在世界范围内仅报道了7例。如果不及早发现,治疗方案可能具有挑战性,并可能导致显著的发病率和死亡率,同时将透析方式转换为血液透析,这是非常不可取的。我们的患者是一名65岁的白人女性,由于怀疑腹膜炎无法进行腹膜透析,需要改为紧急血液透析,随后发现有玫瑰单胞菌粘膜腹膜炎。她在延长抗生素疗程后恢复,并在治疗完成后3个月再次进行腹膜透析。及时诊断和长期使用抗生素是治疗这种罕见微生物以预防腹膜炎死亡率和发病率的基石。
{"title":"<i>Roseomonas mucosa</i>-Induced Peritonitis in a Patient Undergoing Continuous Cycler Peritoneal Dialysis: Case Report and Literature Analysis.","authors":"Sasmit Roy,&nbsp;Sumit Patel,&nbsp;Hardhik Kummamuru,&nbsp;Amarinder Singh Garcha,&nbsp;Rohan Gupta,&nbsp;Sreedhar Adapa","doi":"10.1155/2021/1979332","DOIUrl":"https://doi.org/10.1155/2021/1979332","url":null,"abstract":"<p><p><i>Roseomonas</i> species, a rare Gram-negative microorganism, has seldom been reported to cause peritonitis in end-stage renal disease patients on peritoneal dialysis. Only seven cases of peritonitis by this rare microorganism have been reported worldwide. Treatment options can be challenging if not detected early and can lead to significant morbidity and mortality along with the switching of the dialysis modality to hemodialysis which is highly undesirable. Our patient is a 65-year-old Caucasian female who needed to be changed to emergency hemodialysis due to inability to perform peritoneal dialysis from suspected peritonitis and was subsequently discovered to have peritonitis from <i>Roseomonas mucosa</i>. She recovered with a prolonged antibiotics course and returned to peritoneal dialysis in 3 months following her treatment completion. Prompt diagnosis and prolonged antibiotics are a cornerstone in the management of this rare microorganism to prevent mortality and morbidity from peritonitis.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39609712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Complement Factor H Gene Variant in a Patient with Thrombotic Microangiopathy on a Mixed Clinical Background. 补体因子H基因变异在一个混合临床背景下的血栓性微血管病患者。
Pub Date : 2021-10-25 eCollection Date: 2021-01-01 DOI: 10.1155/2021/2519918
Yoichi Iwafuchi, Tetsuo Morioka, Yuko Oyama, Shin Goto, Ichiei Narita

We report the case of a patient with complement factor H gene variant, who developed thrombotic microangiopathy on a mixed clinical background. A 79-year-old woman was transferred to Sanjo General Hospital for maintenance hemodialysis. She suffered from gastric non-Hodgkin lymphoma about two years ago and received chemotherapy and radiation therapy, leading to complete remission. About 13 weeks prior to her transfer to our hospital, she was referred to another hospital due to acute kidney injury, hemolytic anemia, and thrombocytopenia. Hemodialysis was immediately initiated, after which intravenous methylprednisolone and oral prednisolone were started; however, she became anuric within approximately week. The possibility of thrombotic microangiopathy was examined. However, she was in poor general condition and did not get the consent of her family, so no invasive searches such as a kidney biopsy were performed. Despite the cause of acute kidney insufficiency being unclear, she was transferred to us for maintenance hemodialysis. Her general condition was stable, and her renal function improved; hence, two months after transfer, a kidney biopsy was performed. Her clinical and typical renal histological findings indicated a diagnosis of thrombotic microangiopathy. There was a possible CFH gene of a very rare variant "c.526 T > C (p.Phe176Leu)" in exon 5. She was able to withdraw from hemodialysis therapy two weeks after the initiation of an angiotensin-converting enzyme inhibitor. Based on her clinical course and kidney biopsy findings, she was diagnosed with thrombotic microangiopathy with a very rare CFH variant. To ensure proper treatment choices such as eculizumab, the presence of complement dysregulation should be considered in cases of secondary thrombotic microangiopathy.

我们报告的情况下,患者补体因子H基因变异,谁发展血栓性微血管病的混合临床背景。一名79岁妇女被转送到Sanjo总医院进行维持性血液透析。大约两年前,她患上了胃非霍奇金淋巴瘤,接受了化疗和放疗,病情完全缓解。在转到我院前约13周,她因急性肾损伤、溶血性贫血和血小板减少症转到另一家医院。立即开始血液透析,然后开始静脉注射甲基强的松龙和口服强的松龙;然而,她在大约一周内就无尿了。检查血栓性微血管病变的可能性。然而,由于患者总体状况不佳,且未征得其家人的同意,因此未进行肾活检等侵入性检查。尽管急性肾功能不全的原因尚不清楚,她还是被转到我们这里进行维持性血液透析。患者一般情况稳定,肾功能改善;因此,移植后两个月,进行了肾活检。她的临床和典型的肾脏组织学检查结果显示血栓性微血管病变的诊断。在第5外显子中存在一个非常罕见的变异“C .526 T > C (p.p e176leu)”可能的CFH基因。在开始使用血管紧张素转换酶抑制剂两周后,她能够停止血液透析治疗。根据她的临床过程和肾脏活检结果,她被诊断为血栓性微血管病变,伴有非常罕见的CFH变异。为了确保正确的治疗选择,如eculizumab,在继发性血栓性微血管病变的情况下,应考虑补体失调的存在。
{"title":"Complement Factor H Gene Variant in a Patient with Thrombotic Microangiopathy on a Mixed Clinical Background.","authors":"Yoichi Iwafuchi,&nbsp;Tetsuo Morioka,&nbsp;Yuko Oyama,&nbsp;Shin Goto,&nbsp;Ichiei Narita","doi":"10.1155/2021/2519918","DOIUrl":"https://doi.org/10.1155/2021/2519918","url":null,"abstract":"<p><p>We report the case of a patient with <i>complement factor H</i> gene variant, who developed thrombotic microangiopathy on a mixed clinical background. A 79-year-old woman was transferred to Sanjo General Hospital for maintenance hemodialysis. She suffered from gastric non-Hodgkin lymphoma about two years ago and received chemotherapy and radiation therapy, leading to complete remission. About 13 weeks prior to her transfer to our hospital, she was referred to another hospital due to acute kidney injury, hemolytic anemia, and thrombocytopenia. Hemodialysis was immediately initiated, after which intravenous methylprednisolone and oral prednisolone were started; however, she became anuric within approximately week. The possibility of thrombotic microangiopathy was examined. However, she was in poor general condition and did not get the consent of her family, so no invasive searches such as a kidney biopsy were performed. Despite the cause of acute kidney insufficiency being unclear, she was transferred to us for maintenance hemodialysis. Her general condition was stable, and her renal function improved; hence, two months after transfer, a kidney biopsy was performed. Her clinical and typical renal histological findings indicated a diagnosis of thrombotic microangiopathy. There was a possible CFH gene of a very rare variant \"c.526 T > <i>C</i> (p.Phe176Leu)\" in exon 5. She was able to withdraw from hemodialysis therapy two weeks after the initiation of an angiotensin-converting enzyme inhibitor. Based on her clinical course and kidney biopsy findings, she was diagnosed with thrombotic microangiopathy with a very rare CFH variant. To ensure proper treatment choices such as eculizumab, the presence of complement dysregulation should be considered in cases of secondary thrombotic microangiopathy.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39693178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis 显微镜下多血管炎患者接种SARS-CoV-2 mRNA后的新生和复发性肾小球肾炎
Pub Date : 2021-10-22 DOI: 10.1155/2021/8400842
Tamara Davidovic, J. Schimpf, H. Sprenger-Mähr, Armin Abbassi-Nik, A. Soleiman, E. Zitt, K. Lhotta
Vaccination against SARS-CoV-2 is the most important advance in the fight against the ongoing coronavirus pandemic. Recent case reports show that the SARS-CoV-2 vaccines can very rarely cause de novo or relapsing glomerular disease. Here, we report two female patients with microscopic polyangiitis, who developed severe glomerulonephritis after immunisation with the BNT162b2 mRNA vaccine. One patient with a possible ongoing but undiagnosed disease developed severe necrotising glomerulonephritis after the second vaccination. In the other patient with a long-lasting disease, rituximab maintenance therapy had been postponed because of the coronavirus pandemic. She noted macrohematuria immediately after the second vaccine dose and developed a severe renal relapse leading to end-stage kidney disease. We suggest that patients with ANCA-associated vasculitis be carefully monitored for disease activity immediately before and after receiving the SARS-CoV-2 vaccination, especially if maintenance therapy has been interrupted. Ultimately, mRNA vaccines should probably be avoided in these patients.
针对SARS-CoV-2的疫苗接种是抗击当前冠状病毒大流行的最重要进展。最近的病例报告显示,SARS-CoV-2疫苗很少会引起新生或复发的肾小球疾病。在这里,我们报告了两例显微镜下多血管炎的女性患者,他们在接种BNT162b2 mRNA疫苗后发生了严重的肾小球肾炎。1例可能持续但未确诊疾病的患者在第二次接种后出现严重坏死性肾小球肾炎。在另一名患有长期疾病的患者中,由于冠状病毒大流行,利妥昔单抗维持治疗被推迟。她在第二次接种疫苗后立即出现大量血尿,并出现严重的肾脏复发,导致终末期肾脏疾病。我们建议在接受SARS-CoV-2疫苗接种前后立即仔细监测anca相关血管炎患者的疾病活动,特别是在维持治疗中断的情况下。最终,这些患者可能应该避免使用mRNA疫苗。
{"title":"De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis","authors":"Tamara Davidovic, J. Schimpf, H. Sprenger-Mähr, Armin Abbassi-Nik, A. Soleiman, E. Zitt, K. Lhotta","doi":"10.1155/2021/8400842","DOIUrl":"https://doi.org/10.1155/2021/8400842","url":null,"abstract":"Vaccination against SARS-CoV-2 is the most important advance in the fight against the ongoing coronavirus pandemic. Recent case reports show that the SARS-CoV-2 vaccines can very rarely cause de novo or relapsing glomerular disease. Here, we report two female patients with microscopic polyangiitis, who developed severe glomerulonephritis after immunisation with the BNT162b2 mRNA vaccine. One patient with a possible ongoing but undiagnosed disease developed severe necrotising glomerulonephritis after the second vaccination. In the other patient with a long-lasting disease, rituximab maintenance therapy had been postponed because of the coronavirus pandemic. She noted macrohematuria immediately after the second vaccine dose and developed a severe renal relapse leading to end-stage kidney disease. We suggest that patients with ANCA-associated vasculitis be carefully monitored for disease activity immediately before and after receiving the SARS-CoV-2 vaccination, especially if maintenance therapy has been interrupted. Ultimately, mRNA vaccines should probably be avoided in these patients.","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77264569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
"Recurrent Papillary Necrosis and Nephrocalcinosis Induced by Nonsteroidal Anti-Inflammatory Drugs for Gouty Arthritis Associated with Congenital Chloride-Losing Diarrhea: A Major Risk for Kidney Loss". 非甾体抗炎药引起痛风性关节炎合并先天性氯流失腹泻的复发性乳头状坏死和肾钙质沉着症:肾脏损失的主要风险。
Pub Date : 2021-10-16 eCollection Date: 2021-01-01 DOI: 10.1155/2021/3558278
Kamel El-Reshaid, Shaikha Al-Bader, Hossameldin Sallam

Congenital chloride-losing diarrhea (CCLD) is a rare genetic disorder due to autosomal recessive mutation in the SLC26A3 gene on chromosome 7. It is characterized with chronic watery diarrhea with high fecal chloride (Cl: >90 mmol/L), low potassium (K), and metabolic alkalosis with low urinary Cl and K. The overall long-term prognosis is favorable with optimal life-long salt and K supplementation. In this case report, we describe a man with progressive renal failure and small kidneys that showed nephrocalcinosis and papillary necrosis. His disease was diagnosed since birth and was confirmed by our tests. He was incompliant with therapy and had developed gout. The latter complication of his disease has led to excessive NSAID use over the past years. Reinstitution of diet, drug therapy, and allopurinol had stabilized his renal disease for 1 year of follow-up. In conclusion, excessive analgesic use is a risk factor for renal failure in CCLD.

先天性失氯性腹泻(CCLD)是一种罕见的遗传性疾病,是由7号染色体SLC26A3基因常染色体隐性突变引起的。其特征为慢性水样腹泻伴高粪氯(Cl: >90 mmol/L),低钾(K),代谢性碱中毒伴低尿氯和钾。终生补充盐和钾,总体长期预后良好。在这个病例报告中,我们描述了一个男性进行性肾衰竭和小肾脏,表现为肾钙质沉着和乳头状坏死。他的病从出生时就被诊断出来,我们的检查也证实了这一点。他不接受治疗,患上了痛风。后一种并发症导致他在过去几年过度使用非甾体抗炎药。在1年的随访中,饮食、药物治疗和别嘌呤醇的恢复使他的肾脏疾病稳定下来。综上所述,过度使用镇痛药是CCLD患者肾功能衰竭的危险因素。
{"title":"\"Recurrent Papillary Necrosis and Nephrocalcinosis Induced by Nonsteroidal Anti-Inflammatory Drugs for Gouty Arthritis Associated with Congenital Chloride-Losing Diarrhea: A Major Risk for Kidney Loss\".","authors":"Kamel El-Reshaid,&nbsp;Shaikha Al-Bader,&nbsp;Hossameldin Sallam","doi":"10.1155/2021/3558278","DOIUrl":"https://doi.org/10.1155/2021/3558278","url":null,"abstract":"<p><p>Congenital chloride-losing diarrhea (CCLD) is a rare genetic disorder due to autosomal recessive mutation in the SLC26A3 gene on chromosome 7. It is characterized with chronic watery diarrhea with high fecal chloride (Cl: >90 mmol/L), low potassium (K), and metabolic alkalosis with low urinary Cl and K. The overall long-term prognosis is favorable with optimal life-long salt and K supplementation. In this case report, we describe a man with progressive renal failure and small kidneys that showed nephrocalcinosis and papillary necrosis. His disease was diagnosed since birth and was confirmed by our tests. He was incompliant with therapy and had developed gout. The latter complication of his disease has led to excessive NSAID use over the past years. Reinstitution of diet, drug therapy, and allopurinol had stabilized his renal disease for 1 year of follow-up. In conclusion, excessive analgesic use is a risk factor for renal failure in CCLD.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39877301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Esophageal Necrosis Early after Renal Transplantation. 肾移植术后早期急性食管坏死。
Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5164373
Ahmad Makeen, Faisal Al-Husayni, Turki Banamah

Background: Acute esophageal necrosis (AEN) is defined as a diffused black discoloration of the esophageal mucosa involving mainly the distal part of the esophagus. It is considered a rare clinical entity with a high mortality rate. The etiology of AEN is unknown, but it has been correlated to many causes such as malignancies, infections, and hemodynamics instability. Here, we report a case of a patient developing AEN a few days after kidney transplantation. Case Presentation. A 57-year-old male was admitted electively for kidney transplantation that he received from his son. The surgery was complicated with a significant drop in blood pressure but otherwise was uneventful. The patient was showing good signs of recovery but then suffered from significant hematemesis. An urgent upper esophagogastroduodenoscopy revealed black discoloration of the esophageal mucosa in keeping with AEN. The patient was treated with proton pump inhibitors infusion and started empirically on antivirals and antifungals. The patient's condition improved in regards to the AEN; nonetheless, the complications resulted in graft loss, and the patient returned to hemodialysis.

Conclusion: AEN is a critical condition that mandates early intervention. Identifying high-risk populations may aid in early anticipation and diagnosis. Patients with chronic kidney disease are at risk of atherosclerosis leading to a low flow state which is exacerbated during renal transplantation surgery, especially if the procedure was complicated with a drop in blood pressure.

背景:急性食管坏死(AEN)被定义为食管黏膜弥漫性黑色变色,主要累及食管远端。它被认为是一种罕见的高死亡率临床实体。AEN的病因尚不清楚,但它与许多原因有关,如恶性肿瘤、感染和血流动力学不稳定。在此,我们报告一例肾移植后几天发生AEN的患者。案例演示。一名57岁男性因接受其子肾移植选择性入院。手术很复杂,血压明显下降,但除此之外一切都很顺利。病人有良好的恢复迹象,但后来出现明显的呕血。紧急上食管胃十二指肠镜检查显示食管黏膜黑色变色,符合AEN。患者接受质子泵抑制剂输注治疗,并开始经验性地使用抗病毒和抗真菌药物。患者的病情在AEN方面有所改善;然而,并发症导致移植物丢失,患者再次进行血液透析。结论:AEN是一种危重疾病,需要早期干预。确定高危人群可能有助于早期预测和诊断。慢性肾脏疾病患者有动脉粥样硬化的风险,导致低血流状态,在肾移植手术中加剧,特别是当手术伴有血压下降时。
{"title":"Acute Esophageal Necrosis Early after Renal Transplantation.","authors":"Ahmad Makeen,&nbsp;Faisal Al-Husayni,&nbsp;Turki Banamah","doi":"10.1155/2021/5164373","DOIUrl":"https://doi.org/10.1155/2021/5164373","url":null,"abstract":"<p><strong>Background: </strong>Acute esophageal necrosis (AEN) is defined as a diffused black discoloration of the esophageal mucosa involving mainly the distal part of the esophagus. It is considered a rare clinical entity with a high mortality rate. The etiology of AEN is unknown, but it has been correlated to many causes such as malignancies, infections, and hemodynamics instability. Here, we report a case of a patient developing AEN a few days after kidney transplantation. <i>Case Presentation</i>. A 57-year-old male was admitted electively for kidney transplantation that he received from his son. The surgery was complicated with a significant drop in blood pressure but otherwise was uneventful. The patient was showing good signs of recovery but then suffered from significant hematemesis. An urgent upper esophagogastroduodenoscopy revealed black discoloration of the esophageal mucosa in keeping with AEN. The patient was treated with proton pump inhibitors infusion and started empirically on antivirals and antifungals. The patient's condition improved in regards to the AEN; nonetheless, the complications resulted in graft loss, and the patient returned to hemodialysis.</p><p><strong>Conclusion: </strong>AEN is a critical condition that mandates early intervention. Identifying high-risk populations may aid in early anticipation and diagnosis. Patients with chronic kidney disease are at risk of atherosclerosis leading to a low flow state which is exacerbated during renal transplantation surgery, especially if the procedure was complicated with a drop in blood pressure.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39552967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Can Antinuclear Antibodies (ANA) be Monoclonal? 抗核抗体(ANA)可以单克隆吗?
Pub Date : 2021-09-30 eCollection Date: 2021-01-01 DOI: 10.1155/2021/7006466
Laura Biederman, Anjali A Satoskar, Mohankumar Doraiswamy, Samir Parikh, Brad Rovin, Brian Mussio, Galina Mikhalina, Sergey V Brodsky

Background: Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal nuclear staining by immunofluorescence on kidney biopsy. Case Presentation. Nine cases with predominant stain for kappa or lambda light chain were identified by searching the renal pathology laboratory database for the past 10 years. All cases had positive stain for only kappa (six cases) or lambda (three cases) light chain in the nuclei. Eight out of nine cases had positive nuclear IgG stain, and one case had positive nuclear IgA stain. Among cases with positive nuclear IgG staining, six cases were positive for IgG1 subclass, one case was positive for IgG2 subclass, and one case was positive for IgG3 subclass. All patients with positive IgG nuclear stain, who had testing for ANA, had positive ANA. Patients with positive IgG1 subclass did not have monoclonal protein in the serum or urine, but the patient with positive IgG2 subclass and lambda light chain stain in the nuclei had IgG lambda monoclonal gammopathy.

Conclusions: We identified a new unique pattern of nuclear stain by immunofluorescence in kidney biopsies that suggests the presence of monoclonal ANA. Workup for underlying monoclonal gammopathy is warranted in such patients.

背景:肾活检中免疫荧光核染色常见于血清中抗核抗体(ANA)阳性的患者。这些ANA通常是多克隆的,但在这里,我们报告了9例肾活检中免疫荧光单克隆核染色的不寻常发现。案例演示。通过检索近10年肾脏病理实验室数据库,发现9例以kappa或lambda轻链染色为主。所有病例均有kappa(6例)或lambda(3例)轻链阳性染色。9例患者核IgG染色阳性8例,核IgA染色阳性1例。核IgG染色阳性病例中,IgG1亚类阳性6例,IgG2亚类阳性1例,IgG3亚类阳性1例。IgG核染色阳性的患者经ANA检测均为ANA阳性。IgG1亚类阳性的患者血清和尿液中没有单克隆蛋白,但IgG2亚类阳性且细胞核中有lambda轻链染色的患者有IgG lambda单克隆γ病。结论:我们在肾活检中通过免疫荧光鉴定出一种新的独特的核染色模式,表明单克隆ANA的存在。对这些患者进行潜在的单克隆伽玛病检查是必要的。
{"title":"Can Antinuclear Antibodies (ANA) be Monoclonal?","authors":"Laura Biederman,&nbsp;Anjali A Satoskar,&nbsp;Mohankumar Doraiswamy,&nbsp;Samir Parikh,&nbsp;Brad Rovin,&nbsp;Brian Mussio,&nbsp;Galina Mikhalina,&nbsp;Sergey V Brodsky","doi":"10.1155/2021/7006466","DOIUrl":"https://doi.org/10.1155/2021/7006466","url":null,"abstract":"<p><strong>Background: </strong>Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal nuclear staining by immunofluorescence on kidney biopsy. <i>Case Presentation</i>. Nine cases with predominant stain for kappa or lambda light chain were identified by searching the renal pathology laboratory database for the past 10 years. All cases had positive stain for only kappa (six cases) or lambda (three cases) light chain in the nuclei. Eight out of nine cases had positive nuclear IgG stain, and one case had positive nuclear IgA stain. Among cases with positive nuclear IgG staining, six cases were positive for IgG1 subclass, one case was positive for IgG2 subclass, and one case was positive for IgG3 subclass. All patients with positive IgG nuclear stain, who had testing for ANA, had positive ANA. Patients with positive IgG1 subclass did not have monoclonal protein in the serum or urine, but the patient with positive IgG2 subclass and lambda light chain stain in the nuclei had IgG lambda monoclonal gammopathy.</p><p><strong>Conclusions: </strong>We identified a new unique pattern of nuclear stain by immunofluorescence in kidney biopsies that suggests the presence of monoclonal ANA. Workup for underlying monoclonal gammopathy is warranted in such patients.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39505844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycoplasma pneumoniae Infection Associated C3 Glomerulopathy Presenting as Severe Crescentic Glomerulonephritis. 肺炎支原体感染相关的C3肾小球病变表现为严重新月状肾小球肾炎。
Pub Date : 2021-09-27 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6295543
Lalani De Silva, Dinesha Jayasinghe, Priyani Amarathunga

C3 glomerulopathy (C3GP) is a group of diseases caused by a deregulated complement system, which encompasses both dense deposit disease and C3 glomerulonephritis. Renal manifestations of C3GP are primarily of proliferative glomerulonephritis, and only a few case reports of crescentic glomerulonephritis (CGN) in association with C3GP are available. Here is a case of an adult South-Asian female, who was diagnosed as seropositive acute Mycoplasma pneumoniae infection, with associated systemic manifestations, including immune-type extravascular haemolysis and nephrotic range proteinuria. Subsequent renal biopsy revealed CGN with disrupted Bowman's capsules and necrotizing lesions. Immunofluorescence showed coarse granular mesangial C3 deposits with negative IgM, IgG, IgA, and C1q. The immunomorphological phenotype raised two possibilities including C3GP and infection-related glomerulonephritis (IRGN). Persistent proteinuria with no evidence of resolution even after 6 months of follow-up favoured C3GP over IRGN. The patient proceeded to end-stage renal failure requiring renal replacement despite aggressive immunosuppression. This case illustrates the rare association of CGN with C3GP induced by Mycoplasma pneumoniae infection, highlighting the importance of correct diagnosis as well as timely identification of triggering factors in CGN on patient outcome.

C3肾小球病(C3GP)是补体系统失调引起的一组疾病,包括致密沉积病和C3肾小球肾炎。C3GP的肾脏表现主要为增生性肾小球肾炎,仅有少数与C3GP相关的月牙形肾小球肾炎(CGN)病例报道。这是一例南亚成年女性,被诊断为血清阳性急性肺炎支原体感染,伴有相关的全身表现,包括免疫性血管外溶血和肾病范围蛋白尿。随后的肾活检显示CGN伴有鲍曼囊破裂和坏死性病变。免疫荧光显示粗颗粒状系膜C3沉积,IgM、IgG、IgA和C1q阴性。免疫形态学表型提出两种可能性,包括C3GP和感染相关性肾小球肾炎(IRGN)。即使在6个月的随访后,没有证据表明持续性蛋白尿比IRGN更有利于C3GP。患者进展到终末期肾衰竭,尽管有积极的免疫抑制,但仍需要肾脏替代。本病例说明了CGN与肺炎支原体感染引起的C3GP的罕见关联,突出了正确诊断和及时识别CGN触发因素对患者预后的重要性。
{"title":"<i>Mycoplasma pneumoniae</i> Infection Associated C3 Glomerulopathy Presenting as Severe Crescentic Glomerulonephritis.","authors":"Lalani De Silva,&nbsp;Dinesha Jayasinghe,&nbsp;Priyani Amarathunga","doi":"10.1155/2021/6295543","DOIUrl":"https://doi.org/10.1155/2021/6295543","url":null,"abstract":"<p><p>C3 glomerulopathy (C3GP) is a group of diseases caused by a deregulated complement system, which encompasses both dense deposit disease and C3 glomerulonephritis. Renal manifestations of C3GP are primarily of proliferative glomerulonephritis, and only a few case reports of crescentic glomerulonephritis (CGN) in association with C3GP are available. Here is a case of an adult South-Asian female, who was diagnosed as seropositive acute <i>Mycoplasma pneumoniae</i> infection, with associated systemic manifestations, including immune-type extravascular haemolysis and nephrotic range proteinuria. Subsequent renal biopsy revealed CGN with disrupted Bowman's capsules and necrotizing lesions. Immunofluorescence showed coarse granular mesangial C3 deposits with negative IgM, IgG, IgA, and C1q. The immunomorphological phenotype raised two possibilities including C3GP and infection-related glomerulonephritis (IRGN). Persistent proteinuria with no evidence of resolution even after 6 months of follow-up favoured C3GP over IRGN. The patient proceeded to end-stage renal failure requiring renal replacement despite aggressive immunosuppression. This case illustrates the rare association of CGN with C3GP induced by <i>Mycoplasma pneumoniae</i> infection, highlighting the importance of correct diagnosis as well as timely identification of triggering factors in CGN on patient outcome.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39516425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Mutation in the SLC2A9 Gene: A New Family with Familial Renal Hypouricemia Type 2. SLC2A9基因突变:家族性2型肾性高尿酸血症的一个新家族。
Pub Date : 2021-09-23 DOI: 10.1155/2021/4751099
Christian Maalouli, Karin Dahan, Arnaud Devresse, Valentine Gillion

Familial renal hypouricemia is a rare genetic disorder characterized by a defect in renal tubular urate reabsorption. Some patients present with exercise-induced acute kidney injury and nephrolithiasis. Type II is caused by mutations in the SLC2A9 gene. Here, we report the case of a young patient who developed acute kidney injury after exercise secondary to familial renal hypouricemia type II. The same mutation was found in other asymptomatic members of his family. We review the medical literature on this condition. This case highlights the importance of considering uric acid disorders in the work-up of acute kidney injury after exercise.

家族性肾性高尿酸血症是一种罕见的遗传性疾病,其特征是肾小管尿酸盐重吸收缺陷。一些患者表现为运动诱发的急性肾损伤和肾结石。II型是由SLC2A9基因突变引起的。在这里,我们报告了一例年轻患者,他在运动后发生急性肾损伤,继发于家族性II型肾低尿酸血症。在他的其他无症状家庭成员身上也发现了同样的突变。我们回顾了关于这种情况的医学文献。该病例强调了在运动后急性肾损伤的检查中考虑尿酸障碍的重要性。
{"title":"Mutation in the <i>SLC2A9</i> Gene: A New Family with Familial Renal Hypouricemia Type 2.","authors":"Christian Maalouli,&nbsp;Karin Dahan,&nbsp;Arnaud Devresse,&nbsp;Valentine Gillion","doi":"10.1155/2021/4751099","DOIUrl":"10.1155/2021/4751099","url":null,"abstract":"<p><p>Familial renal hypouricemia is a rare genetic disorder characterized by a defect in renal tubular urate reabsorption. Some patients present with exercise-induced acute kidney injury and nephrolithiasis. Type II is caused by mutations in the <i>SLC2A9</i> gene. Here, we report the case of a young patient who developed acute kidney injury after exercise secondary to familial renal hypouricemia type II. The same mutation was found in other asymptomatic members of his family. We review the medical literature on this condition. This case highlights the importance of considering uric acid disorders in the work-up of acute kidney injury after exercise.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486506/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39482682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Severe Hyponatremia following Hysteroscopic Procedure in a Young Patient: A Case Report and Review of the Literature. 年轻患者宫腔镜手术后急性严重低钠血症1例报告及文献复习。
Pub Date : 2021-09-20 eCollection Date: 2021-01-01 DOI: 10.1155/2021/7195660
Anwar S Atieh, Omar K Abu Shamma, Mohammad O Abdelhafez, Muath A Baniowda, Samia Abed, Basheer H Babaa, Abdurrahman Hamadah, Kamel A Gharaibeh

Background: Hysteroscopic surgery is a minimally invasive procedure used to diagnose and treat intrauterine pathologies. It requires distension of the uterine cavity for the adequate visualization of the operative field. Glycine (1.5%) is one of the most commonly used solutions because it is nonconductive and also has good optical properties. However, acute hyponatremia is a critical complication that can develop after the absorption of a sufficient amount of the irrigation medium. Case Presentation. We report a case of a 43-year-old female patient who developed acute symptomatic hyponatremia (104 mEq/L) and pulmonary edema secondary to hysteroscopic resection of leiomyoma and hastily approached with rapid sodium correction measures.

Conclusion: Multiple strategies can be taken to reduce the risk of fluid absorption and subsequent hyponatremia. Moreover, attention should be paid to the treatment approach for patients with acute hyponatremia following hysteroscopic procedures; rapid correction of acute hyponatremia for such patients might be safe, although there is no consensus in the literature, and further trials are needed.

背景:宫腔镜手术是一种用于诊断和治疗宫内病变的微创手术。它需要扩张子宫腔,以充分显示手术视野。甘氨酸(1.5%)是最常用的溶液之一,因为它不导电,还具有良好的光学性能。然而,急性低钠血症是一种严重的并发症,可在吸收足够量的冲洗介质后发生。案例演示。我们报告了一例43岁的女性患者,她在宫腔镜下切除平滑肌瘤后出现急性症状性低钠血症(104 mEq/L)和肺水肿,并匆忙采取了快速钠矫正措施。结论:可以采取多种策略来降低液体吸收和随后的低钠血症的风险。此外,应注意宫腔镜手术后急性低钠血症患者的治疗方法;对这些患者快速纠正急性低钠血症可能是安全的,尽管在文献中没有共识,需要进一步的试验。
{"title":"Acute Severe Hyponatremia following Hysteroscopic Procedure in a Young Patient: A Case Report and Review of the Literature.","authors":"Anwar S Atieh,&nbsp;Omar K Abu Shamma,&nbsp;Mohammad O Abdelhafez,&nbsp;Muath A Baniowda,&nbsp;Samia Abed,&nbsp;Basheer H Babaa,&nbsp;Abdurrahman Hamadah,&nbsp;Kamel A Gharaibeh","doi":"10.1155/2021/7195660","DOIUrl":"https://doi.org/10.1155/2021/7195660","url":null,"abstract":"<p><strong>Background: </strong>Hysteroscopic surgery is a minimally invasive procedure used to diagnose and treat intrauterine pathologies. It requires distension of the uterine cavity for the adequate visualization of the operative field. Glycine (1.5%) is one of the most commonly used solutions because it is nonconductive and also has good optical properties. However, acute hyponatremia is a critical complication that can develop after the absorption of a sufficient amount of the irrigation medium. <i>Case Presentation</i>. We report a case of a 43-year-old female patient who developed acute symptomatic hyponatremia (104 mEq/L) and pulmonary edema secondary to hysteroscopic resection of leiomyoma and hastily approached with rapid sodium correction measures.</p><p><strong>Conclusion: </strong>Multiple strategies can be taken to reduce the risk of fluid absorption and subsequent hyponatremia. Moreover, attention should be paid to the treatment approach for patients with acute hyponatremia following hysteroscopic procedures; rapid correction of acute hyponatremia for such patients might be safe, although there is no consensus in the literature, and further trials are needed.</p>","PeriodicalId":9604,"journal":{"name":"Case Reports in Nephrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39474885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Case Reports in Nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1